Morgan Joseph Reiterates a 'Buy' on Nektar Technology (NKTR); Sees Substantial Added Value From AstraZeneca Deal
Go back to Morgan Joseph Reiterates a 'Buy' on Nektar Technology (NKTR); Sees Substantial Added Value From AstraZeneca Deal| ASTRAZENECA PLC (NASDAQ: AZN) | Delayed: 92.77 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $92.77 | 52 Week High | $35.04 | |||
| Open | $92.77 | 52 Week Low | $26.97 | |||
| Day High | $92.77 | P/E | N/A | |||
| Day Low | $92.77 | EPS | $0.00 | |||
| Volume | 3,817,855 | |||||
| Nektar Therapeutics (NASDAQ: NKTR) | Delayed: 76.08 +2.44 (3.31%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $73.64 | 52 Week High | $19.98 | |||
| Open | $75.00 | 52 Week Low | $10.52 | |||
| Day High | $76.22 | P/E | N/A | |||
| Day Low | $73.43 | EPS | $-1.45 | |||
| Volume | 730,781 | |||||
